Asset Lead, Oncology Outcomes Research

Do you have expertise in, and passion for Medical Affairs in Oncology? AstraZeneca’s vision in Oncology is to help patients by redefining the cancer-treatment paradigm with the bold ambition to eliminate cancer as a cause of death. We are proud to work on ground breaking science with one of the broadest and deepest Oncology pipelines in the business. Help to advance our pipeline by applying expertise and accelerating our pathway to finding a cure.
We are seeking an Asset Lead, Oncology Outcomes Research (O2R) Group Director who will report to the Tumor Lead for Oncology Outcomes Research. The Asset Lead will be responsible for leading the team of scientists that develop and implement health outcomes and real-world strategies and studies on a global and US market level. This role will also be responsible for strategically communicating to and influencing a diverse group of internal and external partners.
The O2R team develops strategy for and delivers impactful real world, health outcomes, economic and patient reported research. The team's mission is to focus on quantifying and communicating the value proposition. In addition to evidence generation and communication, the team is a strong strategic partner to the Global and Regional medical teams responsible for developing health outcomes strategy in oncology.
This position will be based at our vibrant campus location in Gaithersburg, MD.
What You'll Do:

• Will manage, coach and mentor outcomes researchers with diverse technical skills and enable them to deliver impactful and measurable results.
• Oversees the development of research plans for assets.
• Oversees a team of Outcomes Researchers, which will deliver both the strategy and technical execution of projects for that specific Franchise.
• Participates in key internal review and governance meetings to ensure the scientific rigor of AZ sponsored research including ERT.
• Proactive relationship and communications with key counterparts in GMA, CMLT, USMA, EUCAN, OMAP, International.
• Leads the development and execution of the Global Franchise strategy including real world evidence, and other activities to assess, quantify and communicate the value proposition for AZ’s oncology portfolio.

­­
Minimum Qualifications:

• Minimum 5 years’ experience in the pharmaceutical industry
• Travel-25%
• In-depth expertise with research methods for real world research, HEOR projects including pharmacoepidemiologic models.
• Expert knowledge and application of epidemiological/health outcomes methodology within pharmaceutical industry at an international level.
• Scientific expertise in oncology with knowledge of different data sources

Preferred Qualifications

• Strong written and verbal communication skills as well as strong leadership and interpersonal skills.
• Proven ability with a track record of success in developing and leading teams
• Demonstrated expertise in analytical, judgment and problem-solving skills.
• Capable of managing budgets and resources, and shifting priorities in a rapidly changing environment
• Graduate degree (MS, MPH, PhD) in health economics, epidemiology, outcomes research and/or related fields.

Are you ready to bring new insights and fresh thinking to the table? Brilliant! We have one seat available, and we hope it’s yours. Apply today.
AstraZeneca embraces diversity and equality of opportunity. We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills. We believe that the more inclusive we are, the better our work will be. We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics. We follow all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorization and employment eligibility verification requirements.